1. Home
  2. IIIN vs ASMB Comparison

IIIN vs ASMB Comparison

Compare IIIN & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

IIIN

Insteel Industries Inc.

HOLD

Current Price

$27.34

Market Cap

484.9M

Sector

Industrials

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$30.39

Market Cap

442.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IIIN
ASMB
Founded
1953
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
484.9M
442.9M
IPO Year
1994
2010

Fundamental Metrics

Financial Performance
Metric
IIIN
ASMB
Price
$27.34
$30.39
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$44.20
AVG Volume (30 Days)
278.8K
125.5K
Earning Date
04-16-2026
05-06-2026
Dividend Yield
4.37%
N/A
EPS Growth
112.12
91.78
EPS
0.65
N/A
Revenue
$647,706,000.00
N/A
Revenue This Year
$14.20
N/A
Revenue Next Year
$6.82
$638.39
P/E Ratio
$41.85
N/A
Revenue Growth
22.39
N/A
52 Week Low
$24.35
$13.13
52 Week High
$41.64
$39.71

Technical Indicators

Market Signals
Indicator
IIIN
ASMB
Relative Strength Index (RSI) 41.93 57.87
Support Level $24.35 $26.50
Resistance Level $32.50 $30.58
Average True Range (ATR) 0.94 1.55
MACD 0.30 0.36
Stochastic Oscillator 87.26 71.79

Price Performance

Historical Comparison
IIIN
ASMB

About IIIN Insteel Industries Inc.

Insteel Industries Inc produces and sells prestressed concrete strand (PC strand) and welded wire reinforcement (WWR). PC strand, a high-strength seven-wire cable, is used to strengthen precast concrete in structures like bridges, parking decks, and buildings, enabling longer spans and slimmer designs. WWR includes engineered structural mesh for primary reinforcement, concrete pipe reinforcement for drainage and sewage systems, and standard WWR for crack control in residential and light commercial construction. The company serves markets in the United States and internationally, with the majority of revenue generated in the United States.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

Share on Social Networks: